251 related articles for article (PubMed ID: 16960652)
1. Cerebral atrophy and white matter disruption in chronic schizophrenia.
Andreone N; Tansella M; Cerini R; Rambaldelli G; Versace A; Marrella G; Perlini C; Dusi N; Pelizza L; Balestrieri M; Barbui C; Nosè M; Gasparini A; Brambilla P
Eur Arch Psychiatry Clin Neurosci; 2007 Feb; 257(1):3-11. PubMed ID: 16960652
[TBL] [Abstract][Full Text] [Related]
2. Regional thinning of the cerebral cortex in schizophrenia: effects of diagnosis, age and antipsychotic medication.
Nesvåg R; Lawyer G; Varnäs K; Fjell AM; Walhovd KB; Frigessi A; Jönsson EG; Agartz I
Schizophr Res; 2008 Jan; 98(1-3):16-28. PubMed ID: 17933495
[TBL] [Abstract][Full Text] [Related]
3. Effects of alcohol consumption and antipsychotic medication on brain morphology in schizophrenia.
Nesvåg R; Frigessi A; Jönsson EG; Agartz I
Schizophr Res; 2007 Feb; 90(1-3):52-61. PubMed ID: 17218084
[TBL] [Abstract][Full Text] [Related]
4. Altered white matter/gray matter proportions in the striatum of patients with schizophrenia: a volumetric MRI study.
Tamagaki C; Sedvall GC; Jönsson EG; Okugawa G; Hall H; Pauli S; Agartz I
Am J Psychiatry; 2005 Dec; 162(12):2315-21. PubMed ID: 16330596
[TBL] [Abstract][Full Text] [Related]
5. Extensive gray matter volume reduction in treatment-resistant schizophrenia.
Anderson VM; Goldstein ME; Kydd RR; Russell BR
Int J Neuropsychopharmacol; 2015 Feb; 18(7):pyv016. PubMed ID: 25716781
[TBL] [Abstract][Full Text] [Related]
6. MRI assessment of gray and white matter distribution in Brodmann's areas of the cortex in patients with schizophrenia with good and poor outcomes.
Mitelman SA; Shihabuddin L; Brickman AM; Hazlett EA; Buchsbaum MS
Am J Psychiatry; 2003 Dec; 160(12):2154-68. PubMed ID: 14638586
[TBL] [Abstract][Full Text] [Related]
7. Brain volume changes after withdrawal of atypical antipsychotics in patients with first-episode schizophrenia.
Boonstra G; van Haren NE; Schnack HG; Cahn W; Burger H; Boersma M; de Kroon B; Grobbee DE; Hulshoff Pol HE; Kahn RS
J Clin Psychopharmacol; 2011 Apr; 31(2):146-53. PubMed ID: 21346618
[TBL] [Abstract][Full Text] [Related]
8. Increase in gray matter and decrease in white matter volumes in the cortex during treatment with atypical neuroleptics in schizophrenia.
Molina V; Reig S; Sanz J; Palomo T; Benito C; Sánchez J; Sarramea F; Pascau J; Desco M
Schizophr Res; 2005 Dec; 80(1):61-71. PubMed ID: 16150576
[TBL] [Abstract][Full Text] [Related]
9. Cortical white-matter microstructure in schizophrenia. Diffusion imaging study.
Andreone N; Tansella M; Cerini R; Versace A; Rambaldelli G; Perlini C; Dusi N; Pelizza L; Balestrieri M; Barbui C; Nosè M; Gasparini A; Brambilla P
Br J Psychiatry; 2007 Aug; 191():113-9. PubMed ID: 17666494
[TBL] [Abstract][Full Text] [Related]
10. Brain volume changes in first-episode schizophrenia: a 1-year follow-up study.
Cahn W; Hulshoff Pol HE; Lems EB; van Haren NE; Schnack HG; van der Linden JA; Schothorst PF; van Engeland H; Kahn RS
Arch Gen Psychiatry; 2002 Nov; 59(11):1002-10. PubMed ID: 12418933
[TBL] [Abstract][Full Text] [Related]
11. Absence of regional brain volume change in schizophrenia associated with short-term atypical antipsychotic treatment.
McClure RK; Carew K; Greeter S; Maushauer E; Steen G; Weinberger DR
Schizophr Res; 2008 Jan; 98(1-3):29-39. PubMed ID: 17976957
[TBL] [Abstract][Full Text] [Related]
12. A comprehensive assessment of gray and white matter volumes and their relationship to outcome and severity in schizophrenia.
Mitelman SA; Brickman AM; Shihabuddin L; Newmark RE; Hazlett EA; Haznedar MM; Buchsbaum MS
Neuroimage; 2007 Aug; 37(2):449-62. PubMed ID: 17587598
[TBL] [Abstract][Full Text] [Related]
13. Brain structural changes associated with chronicity and antipsychotic treatment in schizophrenia.
Tomelleri L; Jogia J; Perlini C; Bellani M; Ferro A; Rambaldelli G; Tansella M; Frangou S; Brambilla P;
Eur Neuropsychopharmacol; 2009 Dec; 19(12):835-40. PubMed ID: 19717283
[TBL] [Abstract][Full Text] [Related]
14. Volume changes in gray matter in patients with schizophrenia.
Hulshoff Pol HE; Schnack HG; Bertens MG; van Haren NE; van der Tweel I; Staal WG; Baaré WF; Kahn RS
Am J Psychiatry; 2002 Feb; 159(2):244-50. PubMed ID: 11823266
[TBL] [Abstract][Full Text] [Related]
15. Structural brain abnormalities in chronic schizophrenia at the extremes of the outcome spectrum.
Staal WG; Hulshoff Pol HE; Schnack HG; van Haren NE; Seifert N; Kahn RS
Am J Psychiatry; 2001 Jul; 158(7):1140-2. PubMed ID: 11431237
[TBL] [Abstract][Full Text] [Related]
16. Brain volume reductions in medication-naive patients with schizophrenia in relation to intelligence quotient.
Rais M; Cahn W; Schnack HG; Hulshoff Pol HE; Kahn RS; van Haren NE
Psychol Med; 2012 Sep; 42(9):1847-56. PubMed ID: 22357376
[TBL] [Abstract][Full Text] [Related]
17. Regional change in brain morphometry in schizophrenia associated with antipsychotic treatment.
McClure RK; Phillips I; Jazayerli R; Barnett A; Coppola R; Weinberger DR
Psychiatry Res; 2006 Dec; 148(2-3):121-32. PubMed ID: 17097276
[TBL] [Abstract][Full Text] [Related]
18. Excessive brain volume loss over time in cannabis-using first-episode schizophrenia patients.
Rais M; Cahn W; Van Haren N; Schnack H; Caspers E; Hulshoff Pol H; Kahn R
Am J Psychiatry; 2008 Apr; 165(4):490-6. PubMed ID: 18281413
[TBL] [Abstract][Full Text] [Related]
19. Tract-specific analysis of white matter integrity disruption in schizophrenia.
Kunimatsu N; Aoki S; Kunimatsu A; Abe O; Yamada H; Masutani Y; Kasai K; Yamasue H; Ohtomo K
Psychiatry Res; 2012 Feb; 201(2):136-43. PubMed ID: 22398298
[TBL] [Abstract][Full Text] [Related]
20. A follow-up MRI study of the superior temporal subregions in schizotypal disorder and first-episode schizophrenia.
Takahashi T; Suzuki M; Zhou SY; Tanino R; Nakamura K; Kawasaki Y; Seto H; Kurachi M
Schizophr Res; 2010 Jun; 119(1-3):65-74. PubMed ID: 20051316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
